Transsphenoidal surgery still represents, except for prolactinomas (PRLomas, also named prolactin (PRL)-secreting pituitary tumor), the first-line treatment of PT; however, local invasiveness of the tumor may render surgical resection more difficult, sometimes leading to the use of medical therapies in the first line [4]. Here, PRL is linked to neoplasm.